论文部分内容阅读
目的探讨低分子肝素钙抗凝治疗短暂性脑缺血发作(transient ischemic attack,TIA)的疗效。方法将102例患者随机分为治疗组与对照组,对照组仅采用调整血压、抑制血小板凝集、活血化瘀、改善脑组织代谢等治疗措施;治疗组加用低分子肝素钙抗凝治疗,疗效均7d。结果两组治疗后治疗组TIA 3d、7d症状消失率明显高于对照组,1个月内TIA发作例数明显少于对照组(P<0.05)。结论低分子肝素对TIA的抗凝治疗有效、安全、可行。
Objective To investigate the effect of low molecular weight heparin anticoagulation on transient ischemic attack (TIA). Methods 102 patients were randomly divided into treatment group and control group, the control group only used to adjust blood pressure, inhibition of platelet aggregation, blood circulation, improve brain metabolism and other treatment measures; treatment group with low molecular weight heparin anticoagulant therapy, efficacy All 7d. Results After treatment, the disappearance rate of TIA 3d and 7d in treatment group was significantly higher than that in control group, and the incidence of TIA in one month was significantly less than that in control group (P <0.05). Conclusion Low molecular weight heparin is effective, safe and feasible for anticoagulant therapy of TIA.